Latest Us Department Of Defense Funding News

Immuron Limited reported a narrower half-year loss alongside record sales growth and FDA approval for its IMM-529 drug candidate, signalling promising clinical and commercial momentum.

Bio-Gene Technology Limited reports strong progress in advancing its Flavocide® and Qcide® insecticidal platforms, backed by US Department of Defense funding and key organic certification in the US.

Resolution Minerals has expanded its critical minerals footprint with the acquisition of the Horse Heaven Project in Idaho, complementing its Australian assets and setting the stage for a NASDAQ listing.

International Graphite Limited (ASX, IG6) has signed a cooperation agreement to develop a 3,000 t/y expandable graphite facility in Germany, advancing its global footprint alongside progress at its Collie micronising plant and Springdale project, supported by potential US Department of Defense funding.

Bio-Gene Technology Limited is progressing its development of two novel insecticidal compounds, Qcide and Flavocide, targeting major global markets with strong commercial validation and significant US Department of Defense funding.

Bio-Gene Technology Limited has been awarded two significant grants totaling A$3 million by the US Department of Defense, validating its innovative insecticide technologies Flavocide® and Qcide®. The company is advancing regulatory filings and scaling production to target both military and civilian markets.